Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

7 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Efficacy and tolerability of budesonide/formoterol in one hydrofluoroalkane pressurized metered-dose inhaler in patients with chronic obstructive pulmonary disease: results from a 1-year randomized controlled clinical trial.
Rennard SI, Tashkin DP, McElhattan J, Goldman M, Ramachandran S, Martin UJ, Silkoff PE. Rennard SI, et al. Among authors: mcelhattan j. Drugs. 2009;69(5):549-65. doi: 10.2165/00003495-200969050-00004. Drugs. 2009. PMID: 19368417 Free PMC article. Clinical Trial.
Effect of fixed-dose subcutaneous reslizumab on asthma exacerbations in patients with severe uncontrolled asthma and corticosteroid sparing in patients with oral corticosteroid-dependent asthma: results from two phase 3, randomised, double-blind, placebo-controlled trials.
Bernstein JA, Virchow JC, Murphy K, Maspero JF, Jacobs J, Adir Y, Humbert M, Castro M, Marsteller DA, McElhattan J, Hickey L, Garin M, Vanlandingham R, Brusselle G. Bernstein JA, et al. Among authors: mcelhattan j. Lancet Respir Med. 2020 May;8(5):461-474. doi: 10.1016/S2213-2600(19)30372-8. Epub 2020 Feb 14. Lancet Respir Med. 2020. PMID: 32066536 Clinical Trial.
Comparison of ximelagatran, an oral direct thrombin inhibitor, with enoxaparin for the prevention of venous thromboembolism following total hip replacement. A randomized, double-blind study.
Colwell CW Jr, Berkowitz SD, Davidson BL, Lotke PA, Ginsberg JS, Lieberman JR, Neubauer J, McElhattan JL, Peters GR, Francis CW. Colwell CW Jr, et al. Among authors: mcelhattan jl. J Thromb Haemost. 2003 Oct;1(10):2119-30. doi: 10.1046/j.1538-7836.2003.00368.x. J Thromb Haemost. 2003. PMID: 14521593 Free article. Clinical Trial.
Oral direct thrombin inhibitor ximelagatran compared with warfarin for the prevention of venous thromboembolism after total knee arthroplasty.
Colwell CW Jr, Berkowitz SD, Lieberman JR, Comp PC, Ginsberg JS, Paiement G, McElhattan J, Roth AW, Francis CW; EXULT B Study Group. Colwell CW Jr, et al. Among authors: mcelhattan j. J Bone Joint Surg Am. 2005 Oct;87(10):2169-77. doi: 10.2106/JBJS.D.02184. J Bone Joint Surg Am. 2005. PMID: 16203879 Clinical Trial.